27th June - Starpharma is also in advanced commercial negotiations for marketing rights to VivaGel® BV in North America and expects to announce further licensing arrangements in the near future.
9th July - This is an important achievement for Starpharma and creates significant commercial value. It’s timely from a licensing perspective as this milestone will positively impact the advanced negotiations currently underway for the North American region – and we look forward to making an announcement shortly.”
21st Aug - Annual report mentioned the words "Near future".
We have had near future twice now and shortly once, we must be getting close now.
Come on September.
I
- Forums
- ASX - By Stock
- US Vivagel deal
27th June - Starpharma is also in advanced commercial...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.7¢ |
Change
0.001(1.04%) |
Mkt cap ! $39.58M |
Open | High | Low | Value | Volume |
9.7¢ | 9.8¢ | 9.4¢ | $31.39K | 321.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59000 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 103527 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59000 | 0.095 |
3 | 110524 | 0.094 |
1 | 100000 | 0.093 |
1 | 100000 | 0.092 |
1 | 49413 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 103527 | 4 |
0.098 | 136 | 1 |
0.099 | 94163 | 2 |
0.100 | 162106 | 5 |
0.105 | 116531 | 4 |
Last trade - 12.23pm 29/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |